TRIP13 and colorectal carcinoma: To determine if the regulation of FGFR4 and N‐cadherin by TRIP13 is clinically relevant, we checked the expression of FGFR4 and N‐cadherin, which were downregulated by DCZ0415 treatment or TRIP13 knockdown in CRC cells, in human CRCs, which exhibited high TRIP13 expression.